| # | Country | Total Patents | |
|---|---|---|---|
| #1 | EPO (European Patent Office) | 5 | |
| #2 | Canada | 3 | |
| #3 | Australia | 2 | |
| #4 | WIPO (World Intellectual Property Organization) | 2 | |
| #5 | Sweden | 1 | |
| #6 | United States | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Machines |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Microorganisms | |
| #4 | Peptides | |
| #5 | Unspecified technologies | |
| #6 | Unspecified technologies |
| # | Name | Total Patents |
|---|---|---|
| #1 | Horal Peter | 6 |
| #2 | Svennerholm Bo | 6 |
| #3 | Vahlne Anders | 6 |
| #4 | Czerkinsky Cecil | 5 |
| #5 | Holmgren Jan | 5 |
| #6 | Hermodsson Svante | 4 |
| #7 | Hellstrand Jan Urban Kristoffe | 3 |
| #8 | Hellstrand Kristoffer | 3 |
| #9 | Hermodsson Svante Hermod | 3 |
| #10 | Jeansson Stig | 2 |
| Publication | Filing date | Title |
|---|---|---|
| EP0775197A1 | Enhanced activation of natural killer cells using an nk cell activator and a hydrogen peroxide scavenger or inhibitor | |
| AU8087994A | Inhibition of hiv mucosal infection | |
| EP0594638A1 | Peptides for use in induction of t cell activation against hiv-1 | |
| EP0493468A1 | Anti-tumor preparation comprising interleukin-2 and histamine, analogs thereof or h2-receptor agonists |